The Food and Drug Administration issued a new guidance today that exempts still more medical devices—some of them consumer devices—from its regulatory scope. This means the makers of these devices, some of which are connected to apps, no longer have to go through the FDA's 510(k) review process before they bring their product to market.
FDA will exempt more consumer health devices from pre-market review
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.